Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial †
Titel:
Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial †
Auteur:
Reck, M. Bondarenko, I. Luft, A. Serwatowski, P. Barlesi, F. Chacko, R. Sebastian, M. Lu, H. Cuillerot, J.-M. Lynch, T.J.